(PRESS RELEASE) LONDON, 15-Feb-2021 — /EuropaWire/ — British multinational insurance company Aviva to help its protection customers living with cancer get access to the emotional, clinical and financial support they need through a new partnership agreement with leading UK cancer … Read the full press release
Posted in Healthcare, Insurance, News, United Kingdom
Tagged Aviva, Cancer, cancer diagnosis, charity, COVID-19, critical illness claims, DigiCare+, DigiCare+ Workplace, financial claim payment, insurance, Macmillan Cancer Support, Macmillan Clinical Nurse Specialists, Natasha Parker, NHS, NHS services, pandemic, Paul Brencher, protection claims, protection customers, UK cancer charity
EXETER, 05-Oct-2018 — /EuropaWire/ — An Exeter paper has won Research Paper of the Year under the cancer category in the Royal College for General Practitioners (RCGP) Research Awards. The paper, published in 2017, found that having a high blood platelet … Read the full press release
Posted in Awards, Education, Healthcare, Science, Technology
Tagged Award, Cancer, cancer diagnosis, high blood platelet count, research paper, thrombocytosis, University of Exeter
New test expands cancer diagnostics portfolio and strengthens Roche Diagnostics’ comprehensive tumour marker menu 19-7-2013 — /europawire.eu/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the global launch (except US) of Elecsys ProGRP, a test that distinguishes between the two … Read the full press release
Posted in Business, Healthcare, Pharma & Biotech, Science, Switzerland
Tagged Cancer, cancer diagnosis, lung cancer, non-small cell, NSCLC, ProGRP test, Roche, SCLC, small cell
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
